| Literature DB >> 31211263 |
Kalsoom Akhter1, Kaleem Ullah1, Rabia Talat1, Ali Haider1, Nasir Khalid2, Faizan Ullah3, Saqib Ali1,4.
Abstract
Two new cationic surfactants, n-hexadecyl-3-methylpyridinium bromide and n-heptadecyl-3-methylpyridinium bromide have been synthesized and characterized in solid state by FT-IR, and in solution by 1H- and 13C-NMR spectroscopy. The values of critical micelle concentration (CMC) were determined by UV-visible spectroscopy and conductometry. Interaction of synthesized surfactants with two anionic drugs, i.e., diclofenac sodium {[2-(2, 6-Dichloroanilino) phenyl] acetic acid} and ketoprofen [(RS)-2-(3-benzoylphenyl) propionic acid] was studied by UV-visible spectroscopy. Binding constant (K), Gibb's free energy (ΔG) and number of drug molecules (n) per micelle were also calculated. These synthesized surfactants were proved to be efficient in increasing the solubility and bioavailability of drug molecules. In order to check the carrier efficiency of synthesized surfactants against bioactive coordinate, on complexes, interaction of recently reported bioactive zinc complexes was tested with synthesized cationic surfactants by conductometric measurements. Mole fractions (Xcmc) and Gibbs free energy (ΔGcmc) values were also calculated. Both surfactants were further screened for anti-fungal and anti-bacterial activities.Entities:
Keywords: Analytical chemistry; CMC; Cationic surfactants; Drug-/complex-surfactant interactions; Inorganic chemistry; Pharmaceutical chemistry
Year: 2019 PMID: 31211263 PMCID: PMC6562109 DOI: 10.1016/j.heliyon.2019.e01885
Source DB: PubMed Journal: Heliyon ISSN: 2405-8440
Scheme 1Numbering of carbon and proton atoms of surfactants (I & II) for interpretation of 1H- and 13C-NMR.
Physical properties of surfacntants (I and II).
| Surfacntant | MolecularFormula | Molecular Weight | Physical State | Melting Point (°C) | Color | CMC (m mol dm−3) | Solubility |
|---|---|---|---|---|---|---|---|
| I | C22H40NBr | 398 | Solid | 51–52 | White | 0.243 | Water, Methanol, Ethanol, Acetone, DMSO, Chloroform |
| II | C23H42NBr | 411.9 | Solid | 53–54 | White | 0.239 | As above |
Fig. 1Plots of conductivity and differential conductivity vs concentrations of a) surfactant (I) and b) surfactant (II).
Fig. 2Plots of absorbance and differential absorbance vs concentrations of a) surfactant (I) and b) surfactant (II).
Fig. 3Absorption spectra of diclofenac sodium with a) surfactant (I) and b) surfactant (II).
Fig. 4Plots of 1/ΔA vs 1/Csmo + Ca for a) compound (I) and b) compound (II).
Fig. 5Absorption spectra of KP with a) compound (I) and b) compound (II).
Fig. 6Plots of 1/ΔA vs 1/Csmo + Ca for a) compound (I) and b) compound (II).
Calculated parameters for drug interaction studies.
| Compounds no. | Ao | A | Eo x 105 | Em X 105 | Cm x 10−5 mol/dm3 | Mx 10−5 mol/dm3 | N | K dm3/mol | -ΔG kJ/mol |
|---|---|---|---|---|---|---|---|---|---|
| I + DF | 0.317 | 0.332 | 3.17 | 3.32 | 0.100 | 0.025 | 4 | 2359 | 19.2 |
| II + DF | 0.317 | 0.333 | 3.17 | 3.33 | 0.100 | 0.035 | 3 | 2631 | 19.5 |
| I + KP | 1.267 | 1.252 | 18.1 | 17.8 | 0.070 | 0.14 | 0.5 | 3200 | 20.0 |
| II + KP | 1.267 | 1.003 | 18.1 | 14.7 | 0.077 | 0.17 | 0.4 | 3604 | 20.3 |
Fig. 7Zn (II) Complexes a) [Zn (L1)2] b) [Zn (L2)2].
Fig. 8[Zn (L1)2] interactions with a) compound I and b) compound II.
Fig. 9[Zn (L2)2] interactions with a) compound I and b) compound II.
Calculated parameter for complex interaction studies.
| Compounds no. | Complexes | CMC [mM] | -ΔGm (kJ/mol) |
|---|---|---|---|
| I | Zn(L1)2 | 0.537 | 36.46 |
| II | Zn(L1)2 | 0.375 | 40.51 |
| I | Zn(L2)2 | 0.497 | 39.87 |
| II | Zn(L2)2 | 0.33 | 42.41 |
Anti-bacterial activity of compounds (I & II).
| Compounds no. | ||||
|---|---|---|---|---|
| Zone of inhibition (mm) | ||||
| I | 15 | 21 | 12 | 17 |
| II | 17 | 19 | 9 | 14 |
| Azithromycine | 28 | 24 | 21 | 22 |
| Ciprofloxacine | 22 | 24 | 26 | 29 |
Anti-fungal activity of compounds (I & II).
| Compounds no. | |||
|---|---|---|---|
| % inhibition | |||
| I | 43 | 57 | 55 |
| II | 57 | 59 | 49 |
| Terbenafine | 100 | 100 | 100 |